Efficacyandsafetyoflow-intensityultrasoundtherapyformyofascialpainsyndrome:asystematicreviewandmeta-analysis

Myofascial Pain Syndrome (MPS) is a widespread pain disorder affecting millions of people, characterized by tight knots or trigger points in muscles and fascia that cause localized pain and reduced mobility. Between 30-85% of patients with musculoskeletal pain are diagnosed with MPS, making it one of the most common pain conditions seen in clinical practice. While many treatments exist for MPS, there's been ongoing debate about whether low-intensity ultrasound therapy—a commonly used, non-invasive treatment—actually helps patients with this condition. Some studies have suggested it works, while others have found no benefit compared to placebo treatments.

Researchers conducted a comprehensive systematic review and meta-analysis by searching major medical databases for all randomized controlled trials that tested low-intensity ultrasound therapy in MPS patients. They included 16 high-quality studies involving 1,063 participants with confirmed trigger points in muscles like the trapezius, neck, shoulder, and back regions. The researchers looked at two main comparisons: ultrasound versus sham (fake) treatment or no treatment, and ultrasound versus other active treatments. They measured outcomes including pain intensity using visual analog scales, pressure pain threshold (how much pressure it takes to cause pain), and functional improvement using standardized questionnaires.

The analysis revealed that low-intensity ultrasound therapy provides significant pain relief compared to sham treatment or no treatment. Patients receiving real ultrasound therapy experienced meaningful reductions in pain intensity, with effect sizes indicating moderate to large clinical benefits. The pressure pain threshold also improved significantly, meaning patients could tolerate more pressure on their trigger points after treatment. When compared to other active treatments like dry needling, trigger point injections, or shock wave therapy, ultrasound showed similar effectiveness—neither superior nor inferior.

Importantly, none of the 16 studies reported any adverse events or side effects from ultrasound therapy, suggesting it's a very safe treatment option. However, the researchers found high variability between studies in terms of ultrasound parameters used (frequency, intensity, treatment duration), which made it difficult to determine optimal treatment protocols.

This research provides strong evidence that low-intensity ultrasound therapy is both safe and effective for reducing pain in people with myofascial pain syndrome. For patients suffering from trigger point pain, this means ultrasound therapy can be considered a viable, non-invasive treatment option that doesn't carry the risks associated with injections or medications. For healthcare providers, the findings support using ultrasound therapy as either a standalone treatment or as part of a comprehensive treatment plan for MPS. However, more research is needed to establish standardized treatment protocols, as the studies used widely varying ultrasound parameters.

The lack of adverse events is particularly reassuring for both patients and clinicians considering this treatment option.